Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Intrauterine Devices Market
U.S. Intrauterine Devices Market size was valued at over USD 1.3 billion in 2022. Driven by the supportive regulatory scenario, the market is poised to grow at over 9.5% CAGR from 2023 to 2032.
The U.S. government is the largest donor to family planning and reproductive health in the world. Additionally, it is one of the largest distributor and consumer of contraceptives globally.
Unintended pregnancies cost the U.S. healthcare system around USD 11 billion every year. With growing innovations in the field, the U.S. FDA is granting approval to novel IUDs for the prevention of unintended pregnancies and abortions.
The use of intrauterine contraceptive devices for younger women and those who have never given birth has also been approved by the U.S. FDA. Such a favorable regulatory environment will create a strong impetus for industry progress.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
U.S. Intrauterine Devices Market Size in 2022: | USD 1.3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 9.7% |
2032 Value Projection: | USD 3.4 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 210 |
Tables, Charts & Figures: | 298 |
Segments covered: | Type, Products and Services, End-use, and Zone. |
Growth Drivers: | |
Pitfalls & Challenges: |